BMH BRÄUTIGAM advises Wundex Group on acquisition of ELLIPSA
BMH BRÄUTIGAM has advised the Wundex Group, a portfolio company of the private equity investor capiton, on the acquisition of the wound care specialist ELLIPSA.
The Wundex Group is a leading wound care provider in Germany and offers modern software solutions for wound documentation as well as effective purchasing and logistics concepts for outpatient care as well as for senior and nursing care facilities, clinics and medical practices.
As a medical retailer, ELLIPSA specializes in the outpatient care of chronic wounds and has also developed its own digital education and training platform, which, among other things, facilitates the exchange of knowledge between wound care experts.
The acquisition of ELLIPSA, with locations in Regensburg and Munich, is an important milestone in the ongoing expansion of the Wundex Group.
Background: The BMH BRÄUTIGAM team has been advising Wundex since its acquisition by capiton in March 2021. BMH BRÄUTIGAM regularly advises private equity investors such as capiton on leveraged buyouts - including the acquisition of Wundex - as well as their portfolio companies on strategic acquisitions.
Team BMH BRÄUTIGAM: Till Wansleben, David Thüning, Sabrina Reimer (all Private Equity | Corporate/M&A)